Cases & Deals

Share

Baxalta invests in OncoResponse

May 2016

Client(s) Baxalta Inc.

Jones Day represented Baxalta Inc., a biopharmaceutical manufacturer headquartered in Northern Illinois, in connection with its purchase of Series A Convertible Preferred Stock in a private placement by OncoResponse, an immuno-oncology antibody discovery company.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.